Lazard

The IPO for STR Holdings, Inc. (NYSE: STRI) is open for trading. Shares are trading at $10.92 after pricing 12,300,000 shares at $10.00 per share, below the expected range ...

ENFIELD, Conn.--(BUSINESS WIRE)-- STR Holdings, Inc. (NYSE: STRI) today announced that the initial public offering of 12,300,000 shares of its common stock has been priced at $10.00 per share. The shares began trading today on The New York Stock Exchange under the ticker symbol "STRI." The closing of the offering is expected to take place on November 12. Of the shares being sold, 3,300,000 are being offered by the Company and 9,000,000 shares are being offered by selling stockholders. In addition ...

SAN DIEGO--(BUSINESS WIRE)-- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009. "Our alliances have continued to achieve strong progress with Roche's initiation of the Phase 3 registration trial for subcutaneous Herceptin, and Baxter's completion of patient enrollment in the Phase 3 GAMMAGARD with PH20 pivotal study and the launch of Hylenex in pediatric hydration," said Jonathan Lim ...

FRAMINGHAM, Mass. and SYDNEY, Nov. 6 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN) a leading innovator and provider of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it is scheduled to make presentations at two upcoming investor conferences in November. The first presentation will be made at the Third Annual Canaccord Adams Cardiovascular ...

FT. LAUDERDALE, Fla., Nov. 5, 2009 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq: MAKO) announced today that Maurice R. Ferre, M.D., President and Chief Executive Officer and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will present at the Lazard Capital Markets 6th Annual Healthcare Conference at The St. Regis in New York on Tuesday, November 17, 2009 at 4:40 pm EST. A webcast will be available and may be accessed by visiting MAKO's website at www.makosurgical.com under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation. About MAKO Surgical Corp. MAKO Surgical Corp. is a medical device company that markets both its RIO(R) Robotic-Arm Interactive Orthopedic system (RIO(R)) and its proprietary RESTORIS(R) implants for minimally invasive orthopedic knee procedures. The MAKO RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific ...